Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Amortization of Deferred Charges (2023 - 2025)

Historic Amortization of Deferred Charges for Sanara MedTech (SMTI) over the last 6 years, with Q3 2025 value amounting to $598172.0.

  • Sanara MedTech's Amortization of Deferred Charges rose 12814.27% to $598172.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 37016.6%. This contributed to the annual value of $838965.0 for FY2024, which is 1622862.98% up from last year.
  • As of Q3 2025, Sanara MedTech's Amortization of Deferred Charges stood at $598172.0, which was up 12814.27% from $583920.0 recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Amortization of Deferred Charges ranged from a high of $598172.0 in Q3 2025 and a low of $2055.0 during Q3 2023
  • Its 3-year average for Amortization of Deferred Charges is $270835.4, with a median of $262192.0 in 2024.
  • In the last 5 years, Sanara MedTech's Amortization of Deferred Charges soared by 1335760.62% in 2024 and then skyrocketed by 12814.27% in 2025.
  • Quarter analysis of 3 years shows Sanara MedTech's Amortization of Deferred Charges stood at $3083.0 in 2023, then surged by 13357.61% to $414898.0 in 2024, then soared by 44.17% to $598172.0 in 2025.
  • Its last three reported values are $598172.0 in Q3 2025, $583920.0 for Q2 2025, and $411324.0 during Q1 2025.